BACKGROUND Resveratrol inhibits the growth of ovarian carcinoma cells in vitro through the inhibition of glucose metabolism and the induction of both autophagy and apoptosis. In the current study, we investigated the metabolic and therapeutic effects of resveratrol in vivo. METHODS A fluorescent xenograft mouse model of ovarian cancer was used. Mice were treated with cisplatin, resveratrol, or vehicle alone. Tumor burden was assessed using whole-body imaging. The effect of resveratrol on glucose uptake in vivo was determined using micro-positron emission tomography scanning. To determine whether resveratrol could inhibit tumor regrowth, tumor-bearing mice were treated with cisplatin followed by either daily resveratrol or vehicle. Autophagic response in resected tumors taken from mice treated with resveratrol was examined by transmission electron microscopy. Glycolysis and mitochondrial respiration in ovarian tumor cells after treatment with resveratrol was assessed. RESULTS Mice treated with resveratrol and cisplatin were found to have a significantly reduced tumor burden compared with control animals (P
CITATION STYLE
Tan, L., Wang, W., He, G., Kuick, R. D., Gossner, G., Kueck, A. S., … Liu, J. R. (2016). Resveratrol inhibits ovarian tumor growth in an in vivo mouse model. Cancer, 122(5), 722–729. https://doi.org/10.1002/cncr.29793
Mendeley helps you to discover research relevant for your work.